Differential regulation of telomerase activity by six telomerase subunits
- PMID: 12135483
- DOI: 10.1046/j.1432-1033.2002.03025.x
Differential regulation of telomerase activity by six telomerase subunits
Abstract
Telomerase is a specialized reverse transcriptase responsible for synthesizing telomeric DNA at the ends of chromosomes. Six subunits composing the telomerase complex have been cloned: hTR (human telomerase RNA), TEP1 (telomerase-associated protein 1), hTERT (human telomerase reverse transcriptase), hsp90 (heat shock protein 90), p23, and dyskerin. In this study, we investigated the role of each the telomerase subunit on the activity of telomerase. Through down- or upregulation of telomerase, we found that only hTERT expression changed proportionally with the level of telomerase activity. The other components, TEP1, hTR, hsp90, p23, and dyskerin remained at high and unchanged levels throughout modulation. In vivo and in vitro experiments with antisense oligonucleotides against each telomerase component were also performed. Telomerase activity was decreased or abolished by antisense treatment. To correlate clinical sample status, four pairs of normal and malignant tissues from patients with oral cancer were examined. Except for the hTERT subunit, which showed differential expression in normal and cancer tissues, all other components were expressed in both normal and malignant tissues. We conclude that hTERT is a regulatable subunit, whereas the other components are expressed more constantly in cells. Although hTERT has a rate-limiting effect on enzyme activity, the other telomerase subunits (hTR, TEP1, hsp90, p23, dyskerin) participated in full enzyme activity. We hypothesize that once hTERT is expressed, all other telomerase subunits can be assembled to form a highly active holoenzyme.
Similar articles
-
Function of HSP90 and p23 in the telomerase complex of thyroid tumors.Pathol Res Pract. 2003;199(9):573-9. doi: 10.1078/0344-0338-00464. Pathol Res Pract. 2003. PMID: 14621192
-
HSP90 is a key for telomerase activation and malignant transition in pheochromocytoma.Endocrine. 2003 Dec;22(3):193-201. doi: 10.1385/ENDO:22:3:193. Endocrine. 2003. Retraction in: Endocrine. 2004 Mar-Apr;23(2-3):229. doi: 10.1007/s12020-004-0002-4. PMID: 14709792 Retracted.
-
A novel mechanism for chaperone-mediated telomerase regulation during prostate cancer progression.Cancer Res. 2001 Jun 15;61(12):4791-6. Cancer Res. 2001. PMID: 11406554
-
Expression of telomerase genes in thyroid carcinoma.Int J Oncol. 2002 Aug;21(2):265-72. Int J Oncol. 2002. PMID: 12118320 Review.
-
[Telomerase, cell immortality and cancer].Hokkaido Igaku Zasshi. 2001 May;76(3):127-32. Hokkaido Igaku Zasshi. 2001. PMID: 11481865 Review. Japanese.
Cited by
-
In silico evaluation of TERT inhibition by anticancer drugs.J Mol Model. 2012 Oct;18(10):4739-44. doi: 10.1007/s00894-012-1455-7. Epub 2012 Jun 6. J Mol Model. 2012. PMID: 22669532
-
Glioma: what is the role of c-Myc, hsp90 and telomerase?Mol Cell Biochem. 2006 Feb;283(1-2):1-9. doi: 10.1007/s11010-006-2495-z. Mol Cell Biochem. 2006. PMID: 16444580 Review.
-
A noncoding RNA gene on chromosome 10p15.3 may function upstream of hTERT.BMC Mol Biol. 2009 Feb 2;10:5. doi: 10.1186/1471-2199-10-5. BMC Mol Biol. 2009. PMID: 19187532 Free PMC article.
-
Molecular insights into reprogramming-initiation events mediated by the OSKM gene regulatory network.PLoS One. 2011;6(8):e24351. doi: 10.1371/journal.pone.0024351. Epub 2011 Aug 31. PLoS One. 2011. PMID: 21909390 Free PMC article.
-
Molecular Markers of Telomerase Complex for Patients with Pituitary Adenoma.Brain Sci. 2022 Jul 25;12(8):980. doi: 10.3390/brainsci12080980. Brain Sci. 2022. PMID: 35892421 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials